Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer. | Cell Rep | 2022 | 36577366 | PubTator, text mining | PubMed |
| Editorial: Stromal and immune microenvironment in breast cancer metastasis. | Front Immunol | 2022 | 36561756 | PubTator, text mining | PubMed |
| Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer. | Cancers (Basel) | 2022 | 36551617 | PubTator, text mining | PubMed |
| Elevated histone demethylase KDM5C increases recurrent miscarriage risk by preventing trophoblast proliferation and invasion. | Cell Death Discov | 2022 | 36550096 | PubTator, text mining | PubMed |
| Virus-like Particles for TEM Regulation and Antitumor Therapy. | J Funct Biomater | 2022 | 36547564 | PubTator, text mining | PubMed |
| Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker. | Curr Oncol | 2022 | 36547193 | PubTator, text mining | PubMed |
| Single-cell transcriptomic, transcriptomic, and metabolomic characterization of human atherosclerosis. | Ann Transl Med | 2022 | 36544681 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies C1QA/B+ macrophages with multiple immune checkpoints associated with esophageal squamous cell carcinoma (ESCC) liver metastasis. | Ann Transl Med | 2022 | 36544679 | PubTator, text mining | PubMed |
Plasma proteomics reveals early, broad release of chemokine, cytokine, TNF, and interferon mediators following trauma with delayed increases in a subset of chemokines and cytokines in patients that remain critically ill. | Front Immunol | 2022 | 36532045 | PubTator, text mining | PubMed |
| Biomarkers in psoriatic arthritis: A meta-analysis and systematic review. | Front Immunol | 2022 | 36532039 | PubTator, text mining | PubMed |
| Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy. | Front Immunol | 2022 | 36532019 | PubTator, text mining | PubMed |
| Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19. | Nat Commun | 2022 | 36526616 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. | PeerJ | 2022 | 36518297 | PubTator, text mining | PubMed |
| Heterogeneity of neutrophils in cancer: one size does not fit all. | Cancer Biol Med | 2022 | 36514901 | PubTator, text mining | PubMed |
| Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. | J Neuroinflammation | 2022 | 36510261 | PubTator, text mining | PubMed |
| The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma. | Front Oncol | 2022 | 36505882 | PubTator, text mining | PubMed |
| Enrichment of T-cell proliferation and memory gene signatures of CD79A/CD40 costimulatory domain potentiates CD19CAR-T cell functions. | Front Immunol | 2022 | 36505428 | PubTator, text mining | PubMed |
| γδ T Lymphocytes as a Double-Edged Sword-State of the Art in Gynecological Diseases. | Int J Mol Sci | 2022 | 36499125 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment. | J Clin Med | 2022 | 36498469 | PubTator, text mining | PubMed |
| Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential. | Cancers (Basel) | 2022 | 36497266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=34